AzTrials
AzTrials

Open Type III (A&B)Pediatric and Adolescent Tibial Shaft FracturesNCT05448053

Illizarov Fixation in Open Type III (A&B) Pediatric and Adolescent Tibial Shaft Fractures

A study testing Ilizarov in people with Open Type III (A&B)Pediatric and Adolescent Tibial Shaft Fractures and Ilizarov Fixation, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The Ilizarov method is our usual treatment of choice for open, complex, physeal or unstable fractures and for patients in whom non-operative or other treatments have failed . Read more about this study

Who is it for?
Ages 8 to 16 years
What is being tested?
Ilizarov
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
1 Jan 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Patients aged 8-16 years old.
  • Diagnosed to have open grade IIIA and IIIB tibial fracture according to Gustilo-Anderson fracture classification system.
  • Fractures of the shaft of the tibia or distal tibial fractures involving the ankle joint and were complicated by bone and/or soft-tissue loss of more than 3 cm.
  • An external fixator could be placed in the proximal lower extremity, distal lower extremity, or foot, and normal bone segments available for osteotomy.
  • Admitted in the duration between 1st of January 2022 until end of December 2023.

Who cannot join

  • Patients requiring free flap or local flap transfer to close the wound.
  • Open grade IIIC tibial fractures (with vascular injury).
  • Loss to follow-up.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Assiut university

    Asyut, 71511

    Khaled Gamal, 01141110942, khaledalamir@yahoo.com

    Recruiting

Other trials in Egypt

About this study

Official title: Clinical and Radiographic Evaluation of Illizarov Fixation in Open Type III (A&B) Pediatric and Adolescent Tibial Shaft Fractures

The Ilizarov method is our usual treatment of choice for open, complex, physeal or unstable fractures and for patients in whom non-operative or other treatments have failed .

Read the detailed description

Tibial fractures are the third most common injury involving a long bone in children. Most occur in the distal third, and approximately 10% are open.High-energy injuries with soft tissue compromise or segmental bone loss, present specific challenges. There is a significant risk of nonunion (7.5%),malunion (17%),infection (10%),and loss of reduction (32%).Many forms of treatment are available including a cast, elastic nailing, and external fixation using either a monolateral fixator, or a circular frame . In complex adult tibial fractures, evidence for the effectiveness of definitive external fixation using a circular frame continues to emerge.Fixators may be used for the correction of tibial deformities in children.Currently, only relatively small case series have been published describing their use for trauma in children and adolescents, albeit with good results.

Being tested
Ilizarov

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IlizarovProcedure or surgery

    Also called ORIF with broad DCP

    Ilizarov fixation in open type III pediatric and adolescent tibial shaft fractures

Study groups in NCT05448053
Study groupRoleWhat they receive
Ilizarov deviceExperimentalIlizarov fixation in open type III pediatric tibial shaft fractures
Receives: Procedure: Ilizarov

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Union of tibial fracture

    Assess Union of the fracture using radiographic union scale in tibial fracture(RUST)

    Measured: 1 year

Secondary outcomes (2)
  1. Determine alignment

    Determine alignment using slit scanogram for both Lower limbs

    Measured: 1 year

  2. Patient reported outcome measures

    Patient reported outcome measures using Stanmore limb reconstruction score (SLRS)

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2022
  2. Study start1 Jan 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05448053
Sponsor's protocol ID
Khaled381991
Status last verified
Feb 2022
First submitted
9 Feb 2022
Last updated
7 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Ilizarov in people with Open Type III (A&B)Pediatric and Adolescent Tibial Shaft Fractures and Ilizarov Fixation, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Khaled Gamal (01141110942, Khaledalamir@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Union of tibial fracture (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in